Literature DB >> 31834001

Adherence to Global Initiative for Chronic Obstructive Lung Disease guidelines in the real world: current understanding, barriers, and solutions.

Hasan Ahmad Hasan Albitar1, Vivek N Iyer2.   

Abstract

PURPOSE OF REVIEW: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) provides a comprehensive review and guidance for clinicians managing patients with chronic obstructive pulmonary disease (COPD). However, adherence to GOLD guidelines has been suboptimal over the years. The current review summarizes the current body of literature addressing the multitude of reasons for the lack of adherence to GOLD guidelines in clinical practice. RECENT
FINDINGS: There continue to be several reasons for suboptimal adoption of GOLD guidelines in clinical practice. A primary and recurrent theme appears to be both delayed as well as missed diagnosis of COPD. There are several reasons for this including lack of awareness about current COPD guidelines, lack of availability as well as utilization of office spirometry and improper symptom assessment. Other issues include improper selection of proper pharmacotherapy options, misdiagnosis/mislabeling of COPD phenotypes, lack of smoking cessation counselling as well as enrollment in pulmonary rehabilitation. Potential solutions include adoption of clinical decision support systems, self-care models and careful phenotyping of COPD patients.
SUMMARY: There are currently several barriers for the adoption of GOLD guidelines into routine clinical practice. These barriers are all amenable to systematic solutions that will increase adherence to current GOLD guidelines.

Entities:  

Mesh:

Year:  2020        PMID: 31834001     DOI: 10.1097/MCP.0000000000000655

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  12 in total

1.  A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease.

Authors:  Yahui Shen; Lina Wang; Yunhui Wu; Yingwei Ou; Huiyu Lu; Xin Yao
Journal:  Exp Ther Med       Date:  2021-05-03       Impact factor: 2.447

2.  Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study.

Authors:  Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

3.  Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve.

Authors:  Ruxandra-Mioara Rajnoveanu; Armand-Gabriel Rajnoveanu; Andreea-Bianca Ardelean; Doina Adina Todea; Carmen-Monica Pop; Sabina Antonela Antoniu; Nicoleta Stefania Motoc; Ana Florica Chis; Ariadna Petronela Fildan; Milena Adina Man
Journal:  Medicina (Kaunas)       Date:  2020-08-20       Impact factor: 2.430

4.  Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis.

Authors:  Evdoxia Gogou; Ourania S Kotsiou; Dimitra S Siachpazidou; Maria Pinaka; Charalampos Varsamas; Fotini Bardaka; Irini Gerogianni; Chrysi Hatzoglou; Konstantinos I Gourgoulianis
Journal:  NPJ Prim Care Respir Med       Date:  2021-03-12       Impact factor: 2.871

5.  Muscle weakness assessment in non-hypoxemic COPD out-patients at tertiary care hospitals.

Authors:  Faisal Faiyaz Zuberi; Bader Faiyaz Zuberi; Faiza Sadaqat Ali; Nimrah Bader
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

6.  Zanthoxylum bungeanum Seed Oil Attenuates LPS-Induced BEAS-2B Cell Activation and Inflammation by Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway.

Authors:  Jing Hou; Jun Wang; Jingyi Meng; Xiaoting Zhang; Yuanjing Niu; Jianping Gao; Yun'e Bai; Jiangtao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-24       Impact factor: 2.629

7.  Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals.

Authors:  Dave Singh; Steve Holmes; Claire Adams; Mona Bafadhel; John R Hurst
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-01

8.  Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.

Authors:  Shih-Lung Cheng; Yi-Rong Li; Nicole Huang; Chong-Jen Yu; Hao-Chien Wang; Meng-Chih Lin; Kuo-Chin Chiu; Wu-Huei Hsu; Chiung-Zuei Chen; Chau-Chyun Sheu; Diahn-Warng Perng; Sheng-Hao Lin; Tsung-Ming Yang; Chih-Bin Lin; Chew-Teng Kor; Ching-Hsiung Lin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-18

9.  Acupuncture Point Stimulation Treatments Combined With Conventional Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Cheng-Lin Tsai; Chou-Chin Lan; Chih-Wei Wu; Yun-Chun Wu; Chan-Yen Kuo; I-Shiang Tzeng; Pei-Shan Hsu; Chang-Ti Lee; Po-Chun Hsieh
Journal:  Front Med (Lausanne)       Date:  2021-06-04

10.  A Patient Charter for Chronic Obstructive Pulmonary Disease.

Authors:  John R Hurst; Tonya Winders; Heinrich Worth; Mohit Bhutani; Kevin Gruffydd-Jones; Daiana Stolz; Mark T Dransfield
Journal:  Adv Ther       Date:  2020-11-27       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.